Clinical Trials Logo

In Vitro Fertilization clinical trials

View clinical trials related to In Vitro Fertilization.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02262923 Withdrawn - Clinical trials for in Vitro Fertilization

Dopamine D-2 Antagonist Use in Poor Responders in IVF: a Randomized Controlled Trial

Start date: March 2016
Phase: N/A
Study type: Interventional

Metoclopramide is a dopamine D2 receptor antagonist with antiemetic and gastrokinetic properties which has been approved for use in pregnant women. Women with polycystic ovary syndrome (PCOS) have been found to have lower dopaminergic tone and increased ovarian vascularity and vascular endothelial growth factor (VEGF) levels compared to controls. During ovarian stimulation, PCOS patients exhibit greater sensitivity to gonadotropins and increased follicular development. Administration of dopamine D2 antagonists may mimic the low dopaminergic tone noted in PCOS patients, increase VEGF levels, angiogenesis, and subsequently improve follicular growth during ovarian stimulation. This strategy could be used to improve IVF outcomes in poor responders. The investigators hypothesize that, compared to gonadotropin use alone, the use of metoclopramide in combination with gonadotropins in poor responders undergoing IVF will result in an increased number of mature oocytes obtained at oocyte retrieval and improved IVF outcomes.

NCT ID: NCT00541892 Withdrawn - Infertility Clinical Trials

Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Start date: September 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.